• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    BioMarin`s Biologic Palynziq (pegvaliase) Receives Approval in the U.S.

    FDA

    Biomarin Pharm`s Biological Palynziq (pegvaliase-pqpz) Receives Approval In US

    FDA

    Biomarin Pharm`s Biological Pegvaliase-Pqpz Receives Approval In US

    FDA

    BioMarin, Pioneer in Rare Disease (PKU), Receives FDA Approval Label Expansion

    PRNEWSWIRE

    EU nod for BioMarin’s second PKU therapy Palynziq

    PMLIVE

    Dupixent® (dupilumab) Approved for Severe Asthma by European Commission

    PRESS RELEASE

    EU nod for BioMarin’s second PKU therapy Palynziq

    PMLIVE

    European Commission Approves Palynziq® (pegvaliase injection)

    PR NEWSWIRE

    BioMarin Receives Positive CHMP Opinion in Europe for Palynziq®

    PR NEWSWIRE

    Palynziq (pegvaliase-pqpz) for the Treatment of Phenylketonuria

    DRUG DEVELOPMENT TECH

    Biomarin Pharm’s Generic Palynziq (Pegvaliase-Pqpz ) Receives Supplemental Approval In US

    FDA

    BioMarin scores long-sought FDA nod for PKU drug

    FIERCE PHARMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.